Drugs / ACHN-975
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01870245 | May → Jun 2013 | — | Achaogen, Inc. | Terminated | No outcome recorded |
| Phase 1 | NCT01597947 | May → Dec 2012 | — | Achaogen, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACHN-975 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01597947 ↗ |
| Modality | Small molecule | — CHEMBL3939284 ↗ |
| Route | Intravenous | “Intravenous single dose” NCT01597947 ↗ |